Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells.

AUTOR(ES)

Dani, C

RESUMO

The recent observation made in our laboratory that cellular myc (c-myc) mRNA has a very short half-life in a variety of normal and transformed human cells emphasized the potential importance of post-transcriptional regulation of c-myc gene expression. Jonak and Knight [Jonak, G. J. & Knight, E., Jr. (1984) Proc. Natl. Acad. Sci. USA 81, 1747-1750] have reported a selective reduction of c-myc mRNA accumulation in lymphoblastoid Daudi cells treated with human beta interferon. This provided a suitable situation in which to examine a possible action of negative modulators of c-myc expression at the level of mRNA stability. Our results confirm the observation by Jonak and Knight that c-myc mRNA level is depressed in cells treated with beta interferon and extend it to alpha 2 interferon. Furthermore, we now demonstrate that interferon has no effect on c-myc transcription rate in isolated nuclei but rather reduces the half-life of its mRNA. Conversely, we show that it increases the level of HLA-A2 mRNA by stimulating its transcription.

Documentos Relacionados

• Selective reduction of c-myc mRNA in Daudi cells by human beta interferon.
• Mechanism for discrimination between viral and host mRNA in interferon-treated cells.
• Fate of interferon-treated cells.
• Inhibition of viral mRNA translation in interferon-treated L cells infected with reovirus.
• Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.